The Drug Enforcement Administration (DEA) published a temporary order to schedule five synthetic benzodiazepine substances in Schedule I of...
Reports
NDEWS Hotspot Alerts July 13 – 19, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 24 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
Biden-Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States. Xylazine’s growing role in...
CFSRE's NPS Discovery is pleased to share with you our Q2 2023 NPS Trend Reports — the most timely...
NDEWS Hotspot Alerts June 22 – June 28, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 33 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022
Lisa McElhaney / /Morbidity and Mortality Weekly Report (MMWR) Weekly / June 30, 2023 / 72(26);721–727 Summary What is already known about this...
A new study from the Centers for Disease Control and Prevention found the street drug xylazine surged much earlier...
FDA Federal Register Notice: Psychedelic Drugs: Considerations for Clinical Investigations; Draft Guidance for Industry; Availability
Lisa McElhaney / /The U.S. Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design...
Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers and Health...
Federal Register Notice: Reporting Theft or Significant Loss of Controlled Substance (Final Rule)
Lisa McElhaney / /SUMMARY: The Drug Enforcement Administration (DEA) is publishing this final rule amending the regulations regarding DEA Form 106, used...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024